{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T02:28:00Z","timestamp":1759026480419,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1023\/a:1007092830169","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:59:48Z","timestamp":1040547588000},"page":"317-329","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Several Glucocorticosteroids and PDE4 Inhibitors on Increases in Total Lung Eosinophil Peroxidase (EPO) Levels Following Either Systemic or Intratracheal Administration in Sephadexor Ovalbumin-induced Inflammatory Models"],"prefix":"10.1007","volume":"24","author":[{"given":"David M.","family":"Hammerbeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean M.","family":"Mcgurran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pam L.","family":"Radziszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine A.","family":"Egging","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Hupperts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary W.","family":"Gullikson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"222652_CR1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","volume":"323","author":"J. Bousquet","year":"1990","unstructured":"BOUSQUET, J., P. CHANEZ, J. Y. LACOSTE, G. BARNEON, N. GHAVANIAN, I. ENANDER, P. VENGE, S. AHLSTEDT, J. SIMONY LAFONTAINE, P. GODARD, and F. B. MICHEL. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med., 323:1033-1039.","journal-title":"N. Engl. J. Med."},{"key":"222652_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1398-9995.1993.tb04692.x","volume":"48","author":"M. R. Sears","year":"1993","unstructured":"SEARS, M. R. 1993. The definition and diagnosis of asthma. Allergy, 48:12-16.","journal-title":"Allergy"},{"key":"222652_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0091-6749(91)90323-G","volume":"88","author":"S. J. Szefler","year":"1991","unstructured":"SZEFLER, S. J. 1991. Glucocorticosteroid therapy for asthma: clinical pharmacology. J. Allergy Clin. Immunol., 88:147-165.","journal-title":"J. Allergy Clin. Immunol."},{"key":"222652_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0091-6749(06)80008-4","volume":"90","author":"L. A. Laitinen","year":"1992","unstructured":"LAITINEN, L. A., A. LAITINEN, and T. HAAHTELA. 1992. A comparative study of the effects of an inhaled corticosteroid, budesonide, and \u03b22-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a random, double-blind, parallel-group controlled trial. J. Allergy Clin. Immunol., 90:32-42.","journal-title":"J. Allergy Clin. Immunol."},{"key":"222652_CR5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF01844196","volume":"45","author":"R. P. Schleimer","year":"1993","unstructured":"SCHLEIMER, R. P. 1993. An overview of glucocorticoid anti-inflammatory actions. Eur. J. Clin Pharmacol., 45:S3-S7.","journal-title":"Eur. J. Clin Pharmacol."},{"key":"222652_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1542\/peds.92.1.64","volume":"92","author":"D. G. Tinkelman","year":"1993","unstructured":"TINKELMAN, D. G., C. REED, H. S. NELSON, and K. P. OFFORD. 1993. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics, 92:64-77.","journal-title":"Pediatrics"},{"key":"222652_CR7","first-page":"373","volume":"88","author":"T. Agertft","year":"1994","unstructured":"AGERTFT, T., and S. PEDERSEN. 1994. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Repir. Med., 88:373-381.","journal-title":"Repir. Med."},{"key":"222652_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(94)00749-W","volume":"275","author":"R. E. Santing","year":"1995","unstructured":"SANTING, R. E., C. G. OLYMULDER, K. VAN DER MOLEN, H. MEURS, and J. ZAAGSMA. 1995. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur. J. Pharmacol., 275:75-82.","journal-title":"Eur. J. Pharmacol."},{"key":"222652_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-6147(97)90613-1","volume":"18","author":"M. M. Teixeira","year":"1997","unstructured":"TEIXEIRA, M. M., R. W. GRISTWOOD, N. COOPER, and P. G. HELLEWELL. 1997. Phosphodiesterase(PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol. Sci., 18:164-170.","journal-title":"Trends Pharmacol. Sci."},{"key":"222652_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01982644","volume":"17","author":"L. Kallstrom","year":"1985","unstructured":"KALLSTROM, L., R. BRATTSAND, U. LOVEGREN, E. SVENSJO, and K. ROEMPKE. 1985. A rat model for testing anti-inflammatory action in lung and the effect of glucocorticosteroids(GCS) in this model. Agents and Actions, 17:355-357.","journal-title":"Agents and Actions"},{"key":"222652_CR11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1476-5381.1990.tb14164.x","volume":"101","author":"B. A. Spicer","year":"1990","unstructured":"SPICER, B. A., R. C. BAKER, P. A. HATT, S. M. LAYCOCK, and H. SMITH. 1990. The effects of drugs on sephadex-induced eosinophilia and lung hyper-responsiveness in the rat. Br. J. Pharmacol., 101:821-828.","journal-title":"Br. J. Pharmacol."},{"key":"222652_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02015576","volume":"13","author":"M. J. Linssen","year":"1991","unstructured":"LINSSEN, M. J., O. H. WILHELMS, and H. TIMMERMAN. 1991. Animal models for testing antiinflammatory drugs for treatment of bronchial hyperreactivity in asthma. Pharm. Weekbl. [Sci.], 13:225-237.","journal-title":"Pharm. Weekbl. [Sci.]"},{"key":"222652_CR13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1476-5381.1994.tb17156.x","volume":"113","author":"D. Raeburn","year":"1994","unstructured":"RAEBURN, D., S. L. UNDERWOOD, S. A. LEWIS, V. R. WOODMAN, C. H. BATTRAM, A. TOMKINSON, S. SHARMA, R. JORDAN, J. E. SOUNESS, S. E. WEBBER, and J-A. KARLSSON. 1994. Anti-inflammatory and bronchodilator properties of RP73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol., 113:1423-1431.","journal-title":"Br. J. Pharmacol."},{"key":"222652_CR14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0022-3565(25)22360-6","volume":"270","author":"D. C. Underwood","year":"1994","unstructured":"UNDERWOOD, D. C., C. J. KOTZER, S. BOCHNOWICZ, R. R. OSBORN, M. A. LUTTMANN, D. W. P. HAY, and T. J. TROPHY. 1994. Comparison of phosphodiesterase III, IV and dual III\/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs. J. Pharmacol. Exp. Ther., 270:250-259.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"222652_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/pulp.1995.1005","volume":"8","author":"K. H. Banner","year":"1995","unstructured":"BANNER, K. H., F. MARCHINI, A. BUSCHI, E. MORIGGI, C. SEMERARO, and C. P. PAGE. 1995. The effect of selective phosphodiesterase inhibitors in comparison with other anti-asthma drugs on allergen-induced eosinophilia in guinea pig airways. Pul. Pharmacol., 8:37-42.","journal-title":"Pul. Pharmacol."},{"key":"222652_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1995.tb14910.x","volume":"114","author":"K. Banner","year":"1995","unstructured":"BANNER, K., and C. L. PAGE. 1995. Acute and Chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br. J. Pharmacol., 114:93-98.","journal-title":"Br. J. Pharmacol."},{"key":"222652_CR17","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1476-5381.1996.tb15522.x","volume":"118","author":"B. Hughes","year":"1996","unstructured":"HUGHES, B., D. HOWAT, H. LISLE, M. HOLBROOK, T. JAMES, N. GOZZARD, K. BLEASE, P. HUGHES, R. KINGABY, G. WARRELLOW, R. ALEXANDER, J. HEAD, E. BOYD, M. EATON, M. WALES, B. SMITH, R. OWENS, C. CATTERALL, S. LIMB, A. RUSSELL, R. ALLEN, M. MERRIMAN, D. BLOXHAM, and G. HIGGS. 1996. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP-840, a novel stereo-selective inhibitor of phosphodiesterase type 4. Br. J. Pharmacol., 118:1183-1191.","journal-title":"Br. J. Pharmacol."},{"key":"222652_CR18","first-page":"A623","volume":"155","author":"D. M. Hammerbeck","year":"1997","unstructured":"HAMMERBECK, D. M., A. M. HUPPERTS, S. M. MCGURRAN, and G. W. GULLIKSON. 1997. Effects of several glucocorticosteroids on increases in total lung eosinophil peroxidase(EPO) levels and thymus involution in a sephadex-induced pulmonary inflammation model. Am. J. Respir. Crit. Care Med., 155:A623.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"222652_CR19","first-page":"A623","volume":"155","author":"D. M. Hammerbeck","year":"1997","unstructured":"HAMMERBECK, D. M., S. M. MCGURRAN, A. M. HUPPERTS, J. OCHADA, G. COLICE, and G. W. GULLIKSON. 1997. Effects of several glucocorticosteroids on increases in total lung eosinophil peroxidase(EPO) levels following either systemic or intratracheal administration in sephadex-or ovalbumin-induced inflammatory models. Am. J. Respir. Crit. Care Med., 155:A623.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"222652_CR20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0022-3565(24)37234-9","volume":"284","author":"T. E. Lawrence","year":"1997","unstructured":"LAWRENCE, T. E., L. MILLECCHIA, and J. S. FEDAN. 1997. Fluticasone propionate and pentamidine isethionate reduce airway hyperreactivity, pulmonary eosinophilia and pulmonary dendritic cell response in a guinea pig model of asthma. J. Pharmacol. Exp. Ther., 284:222-227.","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"suppl.122","key":"222652_CR21","first-page":"86","volume":"63","author":"A. Ryrfeldt","year":"1982","unstructured":"RYRFELDT, A., P. ANDERSSON, S. EDSBACKER, M. TONNESSON, D. DAVIES, and R. PAUWELS. 1982. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur. J. Respir. Dis., 63(suppl. 122):86-95.","journal-title":"Eur. J. Respir. Dis."},{"key":"222652_CR22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2165\/00003495-199447020-00007","volume":"47","author":"S. M. Holliday","year":"1994","unstructured":"HOLLIDAY, S. M., D. FAULDS, and E. M. SORKIN. 1994. Inhaled fluticasone propionate: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma. Drugs., 47:318-331.","journal-title":"Drugs."},{"key":"222652_CR23","first-page":"35","volume-title":"The identification of asthma","author":"M. S. Dunnill","year":"1971","unstructured":"DUNNILL, M. S. 1971. The pathology of asthma. In: Porter, R. and J. Birch, eds. The identification of asthma. Edinburgh: Church-Livingston: 35-46."},{"key":"222652_CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/137.1.62","volume":"137","author":"A. J. Wardlaw","year":"1988","unstructured":"WARDLAW, A. J., S. DUNNETTE, G. J. GLEICH, J. V. COLLINS, and A. B. KAY. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am. Rev. Respir. Dis., 137:62-69.","journal-title":"Am. Rev. Respir. Dis."},{"key":"222652_CR25","first-page":"1517","volume":"321","author":"G. J. Gleich","year":"1990","unstructured":"GLEICH, G. J. 1990. The eosinophil and bronchial asthma: current understanding. N. Engl. J. Med., 321:1517-1527.","journal-title":"N. Engl. J. Med."},{"key":"222652_CR26","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI\/WHO Workshop Report. 1995. National Institutes of Health, National Heart, Lung, and Blood Institute."},{"key":"222652_CR27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.115.1.210","volume":"115","author":"J. W. Georgitis","year":"1999","unstructured":"GEORGITIS, J. W. 1999. The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. Chest, 115:210-217.","journal-title":"Chest"},{"key":"222652_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(82)91152-7","volume":"2","author":"W. V. Filley","year":"1982","unstructured":"FILLEY, W. V., K. E. HOLLEY, G. M. KEPHART, and G. J. GLEICH. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet., 2:11-16.","journal-title":"Lancet."},{"key":"222652_CR29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2222.1988.tb02856.x","volume":"18","author":"A. J. Woolcock","year":"1988","unstructured":"WOOLCOCK, A. J., K. YAN, and C. M. SALOME. 1988. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma. Clin. Allergy, 18:165-176.","journal-title":"Clin. Allergy"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007092830169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007092830169\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007092830169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:56:34Z","timestamp":1748264194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007092830169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["222652"],"URL":"https:\/\/doi.org\/10.1023\/a:1007092830169","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"type":"print","value":"0360-3997"},{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}